RudaCure Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$7.5M
- Investors
-
10
RudaCure General Information
Description
Operator of an AI-based drug discovery platform intended to develop treatments for pain and sensory diseases. The company offers ion channel drug discovery platforms, non-opioid pain therapeutics, dry eye disease treatments, and research services, enabling clients to develop and evaluate pharmaceutical treatments for sensory disorders.
Contact Information
Website
www.rudacure.comCorporate Office
- 9 Songdo Mirae-ro
- Yeonsu-gu, Building 1, Number 302
- Incheon, 21988
- South Korea
Corporate Office
- 9 Songdo Mirae-ro
- Yeonsu-gu, Building 1, Number 302
- Incheon, 21988
- South Korea
RudaCure Timeline
RudaCure Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B) | 01-Apr-2024 | $7.5M | Completed | Clinical Trials - Phase 2 | ||
| 7. Accelerator/Incubator | Completed | Clinical Trials - Phase 2 | ||||
| 6. Accelerator/Incubator | 30-Sep-2023 | Completed | Clinical Trials - Phase 2 | |||
| 5. Later Stage VC (Series A) | 30-May-2023 | Completed | Clinical Trials - Phase 2 | |||
| 4. Accelerator/Incubator | 18-Oct-2022 | Completed | Startup | |||
| 3. Accelerator/Incubator | 08-Sep-2022 | Completed | Startup | |||
| 2. Accelerator/Incubator | 16-Sep-2021 | Completed | Startup | |||
| 1. Seed Round | 13-Apr-2021 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
RudaCure Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
RudaCure Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
RudaCure Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| J Curve Investment | Venture Capital | Minority | ||
| Tech Incubator Program for Startup | Accelerator/Incubator | |||
| CKD Venture Capital | Corporate Venture Capital | Minority | ||
| Darae | Venture Capital | Minority | ||
| BiiG WAVE | Accelerator/Incubator |
RudaCure FAQs
-
When was RudaCure founded?
RudaCure was founded in 2018.
-
Where is RudaCure headquartered?
RudaCure is headquartered in Incheon, South Korea.
-
What is the size of RudaCure?
RudaCure has 30 total employees.
-
What industry is RudaCure in?
RudaCure’s primary industry is Pharmaceuticals.
-
Is RudaCure a private or public company?
RudaCure is a Private company.
-
What is RudaCure’s current revenue?
The current revenue for RudaCure is .
-
How much funding has RudaCure raised over time?
RudaCure has raised $12.3M.
-
Who are RudaCure’s investors?
J Curve Investment, Tech Incubator Program for Startup, CKD Venture Capital, Darae, and BiiG WAVE are 5 of 10 investors who have invested in RudaCure.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
